Kazuo Tamura Selected Research

Granulocyte Colony-Stimulating Factor (G-CSF)

5/2018	Costs associated with febrile neutropenia in Japanese patients with primary breast cancer: post-hoc analysis of a randomized clinical trial.
4/2015	Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy.
7/2012	[A multicenter study of epirubicin-docetaxel(ET)as primary chemotherapy for patients with inflammatory breast cancer(IBC)].
1/2007	Thrombocytopenia in association with splenomegaly during granulocyte-colony-stimulating factor treatment in mice is not caused by hypersplenism and is resolved spontaneously.
5/2005	Weekly paclitaxel in the treatment of advanced or metastatic breast cancer previously treated or not treated with docetaxel: a phase II study.
7/2003	[Infection control for the treatment of hematological malignancies: a survey of the Kyushu Hematology Organization for Treatment Study Group (K-HOT)].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuo Tamura Research Topics

Disease

52	Neoplasms (Cancer) 01/2024 - 06/2003
23	Breast Neoplasms (Breast Cancer) 08/2020 - 05/2005
20	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2021 - 06/2003
17	Febrile Neutropenia 11/2020 - 08/2006
12	Neutropenia 02/2021 - 05/2005
11	Lymphoma (Lymphomas) 08/2016 - 04/2002
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 05/2009
8	Nausea 01/2021 - 07/2014
8	Vomiting 01/2021 - 07/2014
7	Infections 12/2014 - 12/2005
6	Fever (Fevers) 01/2022 - 01/2006
6	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 07/2005
5	Mycoses (Diseases, Fungus) 01/2022 - 02/2007
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2019 - 06/2006
5	Multiple Myeloma 08/2013 - 09/2005
4	Hematologic Neoplasms (Hematological Malignancy) 10/2020 - 07/2003
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2019 - 03/2010
4	Disease Progression 01/2019 - 09/2005
4	Neoplasm Metastasis (Metastasis) 05/2014 - 03/2004
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2012 - 06/2003
3	Body Weight (Weight, Body) 01/2022 - 09/2015
3	Drug-Related Side Effects and Adverse Reactions 01/2022 - 08/2012
3	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 07/2021 - 02/2013
3	Leukemia 11/2020 - 12/2005
3	Leukopenia 10/2020 - 05/2005
3	Invasive Fungal Infections 10/2020 - 01/2009
3	Pain (Aches) 08/2020 - 04/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2019 - 12/2014
3	Rheumatoid Arthritis 02/2017 - 04/2013
3	T-Cell Lymphoma (Lymphoma, T Cell) 04/2014 - 03/2004
3	Sepsis (Septicemia) 03/2013 - 04/2004
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2011 - 03/2004
3	Thrombocytopenia (Thrombopenia) 10/2010 - 01/2007
3	B-Cell Lymphoma (Lymphoma, B Cell) 11/2009 - 05/2009
2	Cachexia 01/2022 - 12/2019
2	Anorexia 01/2022 - 12/2019
2	Cardiotoxicity 01/2021 - 04/2010
2	Anemia 10/2020 - 01/2003
2	Hypesthesia (Numbness) 08/2020 - 08/2012
2	Diarrhea 08/2019 - 10/2015
2	Hemorrhagic Cystitis 01/2019 - 08/2012
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2017 - 07/2015
2	Epstein-Barr Virus Infections 02/2017 - 04/2013
2	Necrosis 02/2017 - 04/2004
2	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 02/2013

Drug/Important Bio-Agent (IBA)

18	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 01/2006
16	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2006
10	Docetaxel (Taxotere)FDA Link 05/2018 - 05/2005
9	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 12/2004
7	AnthracyclinesIBA 01/2021 - 01/2008
7	Rituximab (Mabthera)FDA Link 07/2015 - 05/2009
7	Vincristine (Oncovin)FDA LinkGeneric 05/2010 - 12/2007
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2005
6	Proteins (Proteins, Gene)FDA Link 07/2021 - 03/2004
6	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2018 - 07/2003
6	Bortezomib (Velcade)FDA Link 09/2015 - 03/2008
6	Epirubicin (Ellence)FDA LinkGeneric 01/2015 - 01/2008
5	AntiemeticsIBA 01/2021 - 10/2015
4	Micafungin (FK463)FDA Link 11/2020 - 01/2009
4	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 04/2004
4	Capecitabine (Xeloda)FDA Link 01/2019 - 03/2007
4	pegfilgrastim (Neulasta)FDA Link 05/2018 - 04/2015
4	AntigensIBA 08/2017 - 05/2009
4	Meropenem (Merrem)FDA LinkGeneric 01/2015 - 12/2011
4	Cefepime (Maxipime)FDA LinkGeneric 01/2015 - 08/2006
4	Anti-Bacterial Agents (Antibiotics)IBA 12/2013 - 11/2003
4	AminoglycosidesIBA 02/2013 - 12/2005
4	Prednisolone (Predate)FDA LinkGeneric 05/2010 - 05/2009
3	Antifungal AgentsIBA 10/2020 - 12/2005
3	Irinotecan (Camptosar)FDA LinkGeneric 08/2020 - 04/2004
3	Monoclonal AntibodiesIBA 08/2017 - 12/2014
3	Methotrexate (Mexate)FDA LinkGeneric 02/2017 - 04/2013
3	mogamulizumabIBA 10/2015 - 03/2010
3	Dacarbazine (DIC)FDA LinkGeneric 08/2015 - 01/2006
3	Glucose (Dextrose)FDA LinkGeneric 12/2014 - 12/2007
3	Dexamethasone (Maxidex)FDA LinkGeneric 08/2013 - 04/2004
3	Carbapenems (Carbapenem Antibiotics)IBA 02/2013 - 08/2006
3	DNA (Deoxyribonucleic Acid)IBA 08/2012 - 03/2002
3	InterferonsIBA 12/2010 - 05/2007
3	RetinoidsIBA 03/2010 - 08/2007
3	Arsenic Trioxide (Trisenox)FDA Link 03/2008 - 04/2004
2	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2019
2	Ghrelin ReceptorsIBA 01/2022 - 12/2019
2	anamorelinIBA 01/2022 - 12/2019
2	Etoposide (VP 16)FDA LinkGeneric 12/2021 - 12/2007
2	DEET (DET)IBA 11/2020 - 10/2020
2	Epithelial Cell Adhesion MoleculeIBA 09/2019 - 02/2013
2	AfatinibIBA 08/2019 - 01/2019
2	forodesineIBA 01/2019 - 12/2018
2	eribulin FDA Link 04/2017 - 01/2017
2	Taxoids (Taxanes)IBA 04/2017 - 01/2008
2	human ERBB2 proteinIBA 01/2017 - 01/2013

Therapy/Procedure

52	Therapeutics 01/2022 - 03/2002
41	Drug Therapy (Chemotherapy) 01/2023 - 04/2002
5	Hematopoietic Stem Cell Transplantation 11/2020 - 12/2015
5	Combination Drug Therapy (Combination Chemotherapy) 12/2015 - 06/2003
4	Intravenous Infusions 01/2016 - 02/2009
3	Adjuvant Chemotherapy 05/2018 - 04/2009
3	Radiotherapy 01/2006 - 04/2002
2	Genomic Medicine 01/2024 - 08/2021